EDBI to be a part of Moderna’s funding for innovative drug discovery
Date: 2018-02-02   Author: Saipriya Iyer  Category: #market

EDBI to be a part of Moderna’s funding for innovative drug discovery

EDBI, a dedicated corporate investment segment of the Singapore Economic Development Board, is apparently on the verge of making an investment in Moderna Therapeutics, a U.S. based biotech firm, along with numerous other investors. Reliable sources claim that through the first round of its fund-raising program, Moderna is likely to raise nearly USD 500 million, aided by investors such as EDBI, ADIA, Julius Baer, Sequoia Capital China, and BB Biotech AG.

For the uninitiated, Moderna Therapeutics is renown to develop medicines & vaccines based on mRNA to fulfill unmet medical requirements. Post these major investments, the firm is likely to promote its drug & vaccine development activities on a larger scale and effectively implement its rapidly increasing drug development pipeline of 19 drug candidates encompassing 10 drug tests on humans.

Experts stated that the funds are also expected to be utilized by Moderna in its research activities such as new drug innovation for rare diseases as well as prophylactic injections. Apparently, the investments will be further utilized to modernize the firm’s drug development infrastructure and support its mRNA-based vaccine creating programs.

Post the initial round of fundraising, Moderna has claimed that it has collected approximately USD 1.4 billion in cash in addition to about USD 250 million that it received from the organizations such as Bill & Melinda Gates Foundation, BARDA, and DARPA. Moderna has also collaborated with reputed pharma firms such as Vertex Pharmaceuticals, Alexion, and AstraZeneca to promote its drug development activities for treating rare diseases.

Reports state that Moderna had been permitted to raise its stocks at USD 10.6 per share and USD 7.5 billion valuation. Though the firm has claimed to have gathered investments estimated at USD 500 million from new & existing investors via the latest fundraising, it is of the view that the evaluation is lesser than the predicted estimation of approximately USD 7 billion.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Worldwide N-Methylethanolamine Market Forecast 2021-2026 Growth Drivers, Regional Outlook
Author: Ashwin Naphade

Market Study Report, LLC, has added an exhaustive research study of the ' N-Methylethanolamine market', detailing every single market driver and intricately analyzing the business vertical. This ' N-Methylethanolamine market' study...


2026 Projections: Transient Voltage Suppressor Diodes Market Report by Type, Application and Regional Outlook
Author: Ashwin Naphade

The ' Transient Voltage Suppressor Diodes market' report added recently by Market Study Report, LLC, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a prec...


Worldwide Oxygen Regulator Market Study for 2021 to 2026 providing information on Key Players, Growth Drivers and Industry challenges
Author: Ashwin Naphade

The ' Oxygen Regulator market' report Added by Market Study Report, LLC, enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive i...